Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex

Annals of the Rheumatic Diseases

Volumn 59, Issue 3, 2000, Pages 211-216

  Demetter, P ^a   Cuvelier, C A ^a   Mielants, H ^a   Veys, E M ^a   Baeten, D ^a   De Keyser, F ^a   De Vos, M ^a   van Damme, N ^a   Verbruggen, G ^a   Vermeulen, S ^b   Mareel, M ^b   Elewaut, D ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CATENIN; PLAKOGLOBIN; POLYCLONAL ANTIBODY; UVOMORULIN;

ARTICLE; COLON BIOPSY; COMPLEX FORMATION; ENTEROPATHY; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR UPREGULATION; RNA PROBE; SPONDYLOARTHROPATHY;

ACUTE DISEASE; ADULT; ALPHA CATENIN; BETA CATENIN; CADHERINS; CHILD; CHRONIC DISEASE; CYTOSKELETAL PROTEINS; DESMOPLAKINS; FEMALE; GAMMA CATENIN; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; SPONDYLITIS; TRANS-ACTIVATORS; UP-REGULATION;

EID: 0034108541     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.3.211     Document Type: Article

References (36)

1. 1 Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991;251:1451-5.
2. 2 Smith MEF, Pignatelli M. The molecular histology of neoplasia: the role of the cadherin/catenin complex. Histopathology 1997;31:107-11.
3. 3 Ozawa M, Ringwald M, Kemler R. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci USA 1990;87:4246-50.
4. 4 Nagafuchi A, Takeichi M. Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J 1988;7:3679-84.
5. 5 Nathke IS, Hinck L, Swedlow JR, Papkoff J, Nelson WJ. Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells. J Cell Biol 1994;125:1341-52.
6. 6 Hinck L, Nathke IS, Papkoff J, Nelson WJ. Dynamics of cadherin catenin complex formation: novel protein interaction and pathways of complex assembly. J Cell Biol 1997;125:1327-40.
7. 7 Valizadeh A, Karayiannakis AJ, El-Hariry I, Kmiot W, Pignatelli M. Expression of
8. 8 E-cadherin-associated molecules (α-, β-and γ-catenins and p120) in colorectal polyps. Am J Pathol 1997;150:1977-84.
9. 9 Jou TS, Stewart DB, Stappert J, Nelson WJ, Marrs JA. Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. Proc Natl Acad Sci USA 1995;92:5067-71.
10. 10 Bracke ME, Van Roy FM, Mareel M. The E-cadherin/ catenin complex in invasion and metastasis. In: Günthert U, Birchmeier W, eds. Attempts to understand metastasis formation I. Berlin: Springer, 1996:123-61.
11. 11 Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993;5:806-11.
12. 12 Mareel M, Bracke M, Van Roy F. Invasion promoter versus invasion suppressor molecules: the paradigm of E-cadherin. Mol Biol Rep 1994;19:45-67.
13. 13 Inomata M, Ochiai A, Akimoto S, Kitano S, Hirohashi S. Alteration of β-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. Cancer Res 1996;56:2213-17.
14. 14 Mielants H, Veys EM, Cuvelier C, De Vos M. Ileocolonoscopic findings in seronegative spondylarthropathies. Br J Rheumatol 1988;27:95-105.
15. 15 Cuvelier C, Barbatis C, Mielants H, De Vos M, Roels H, Veys E. Histopathology of intestinal inflammation related to reactive arthritis. Gut 1987;28:394-401.
16. 16 De Vos M, Cuvelier C, Mielants H, Veys E, Barbier F, Elewaut A. Ileocolonoscopy in seronegative spondylarthropathy. Gastroenterology 1989;96:339-44.
17. 17 De Vos M, Mielants H, Cuvelier C, Elewaut A, Veys E. Long term evolution of gut inflammation in patients with spondylarthropathy. Gastroenterology 1996;110:1696-703.
18. 18 Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
19. 19 Cuvelier C, Mielants H, De Vos M, Veys E, Roels H. Major histocompatibility complex class II antigen (HLA-DR) expression by ileal epithelial cells in patients with seronegative spondylarthropathy. Gut 1990;31:545-9.
20. 20 Logel J, Dill D, Leonard S. Synthesis of cRNA probes from PCR-generated DNA. Biotechniques 1992;13:604-10.
21. 21 Bussemakers MJ, van Bokhoven A, Mees SG, Kemler R, Schalken JA. Molecular cloning and characterization of the human E-cadherin cDNA. Mol Biol Rep 1993;17:123-8.
22. 22 Demetter P, Cesmeli E, De Vos M, Bullock G, Van Damme N, Baeten D, et al. Upregulation of E-cadherin and associated molecules (α-, β-and γ-catenins) in inflamed bowel mucosa. Gastroenterology 1998;114:A962.
23. 23 Elewaut D, Van Damme N, Baeten D, Demetter P, Sas S, De Vos M, et al. Intestinal mucosa of patients with spondyloarthropathy is enriched with T cells carrying αEβ7 integrin, even in the absence of histologically defined inflammation. Gastroenterology 1999;116:A706.
24. 7 integrin. Nature 1994;372:190-3.
25. 25 Efsthathiou JA, Noda M, Rowan A, Dixon C, Chinery R, Jawhari A, et al. Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. Proc Natl Acad Sci USA 1998;95:3122-7.
26. 26 Wright NA, Poulsom R, Stamp G, Van Noorden S, Sarraf C, Elia G, et al. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 1993;104:12-20.
27. 27 Poulsom R, Chinery R, Sarraf C, Lalani E-N, Stamp G, Elia G, et al. Trefoil peptide gene expression in intestinal adaptation and renewal. Scand J Gastroenterol 1992;27 (suppl 193):17-28.
28. 28 Wright NA, Poulsom R, Stamp GWH, Hall A, Jeffery RE, Longcroft JM, et al. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol 1990;162:279-84.
29. 29 Kindon H, Pothoulakis C, Thim L, Lynch-Devaney K, Podolsky DK. Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology 1995;109: 516-23.
30. 30 Alison MR, Chinery R, Poulsom R, Ashwood P, Longcroft JM, Wright NA. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach. J Pathol 1995;175: 405-14.
31. 31 Monteleone G, Biancone L, Marasco R, Morrone G, Marasco O, Luzza F, et al. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997;112: 1169-78.
32. 32 Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, et al. Type I T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997;150:823-32.
33. 33 Hiscox S, Hallet MB, Puntis MCA, Jiang WG. Inhibition of cancer cell motility and invasion by interleukin-12. Clin Exp Metastasis 1995;13:396-404.
34. 34 Bailey CJ, Hembry RM, Alexander A, Irving MH, Grant ME, Shuttleworth CA. Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine. J Clin Pathol 1994;47:113-16.
35. 35 Saarialho-Kere UK, Vaalamo M, Puolakkainen P, Airola K, Parks WC, Karjalainen-Lindsberg M-L. Enhanced expression of matrylisin, collagenase, and stromelysin-1 in gastrointestinal ulcers. Am J Pathol 1996;148:519-26.
36. 36 Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, Bissell MJ. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol 1997;139:1861-72.